Fatih Teker

509 total citations
21 papers, 312 citations indexed

About

Fatih Teker is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Fatih Teker has authored 21 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Fatih Teker's work include Inflammatory Biomarkers in Disease Prognosis (4 papers), Liver Disease Diagnosis and Treatment (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Fatih Teker is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (4 papers), Liver Disease Diagnosis and Treatment (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Fatih Teker collaborates with scholars based in Türkiye. Fatih Teker's co-authors include İdris Yücel, Yasemi̇n Kemal, Güzin Demirağ, Meltem Özdemir, Umut Elboğa, Özlem Nuray Sever, Ertan Şahin, Gökmen Aktaş, Havva Yeşil Çınkır and Y. Zeki Çelen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Fatih Teker

20 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fatih Teker Türkiye	7	265	99	83	61	52	21	312
Özlem Erçelep Türkiye	12	175 0.7×	44 0.4×	72 0.9×	145 2.4×	31 0.6×	55	366
Ashvin Paramanathan Australia	7	238 0.9×	48 0.5×	113 1.4×	94 1.5×	17 0.3×	7	326
Dong Soo Lee South Korea	11	90 0.3×	67 0.7×	52 0.6×	87 1.4×	84 1.6×	32	290
Yasemi̇n Kemal Türkiye	9	264 1.0×	75 0.8×	56 0.7×	81 1.3×	26 0.5×	27	334
Nam Kwon Lee South Korea	11	166 0.6×	167 1.7×	143 1.7×	93 1.5×	72 1.4×	34	396
Guochen Duan China	9	234 0.9×	81 0.8×	64 0.8×	93 1.5×	23 0.4×	30	323
Arzu Oğuz Türkiye	9	205 0.8×	63 0.6×	53 0.6×	60 1.0×	23 0.4×	36	310
Cui-jian Zhang China	6	201 0.8×	82 0.8×	97 1.2×	92 1.5×	22 0.4×	14	303
David Chan Australia	7	287 1.1×	107 1.1×	90 1.1×	82 1.3×	42 0.8×	23	377
Jun-Zhong Lin China	9	376 1.4×	100 1.0×	189 2.3×	61 1.0×	21 0.4×	18	431

Countries citing papers authored by Fatih Teker

Since Specialization

Citations

This map shows the geographic impact of Fatih Teker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatih Teker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatih Teker more than expected).

Fields of papers citing papers by Fatih Teker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatih Teker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatih Teker. The network helps show where Fatih Teker may publish in the future.

Co-authorship network of co-authors of Fatih Teker

This figure shows the co-authorship network connecting the top 25 collaborators of Fatih Teker. A scholar is included among the top collaborators of Fatih Teker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatih Teker. Fatih Teker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Teker, Fatih, et al.. (2024). Relationship of Neoadjuvant Chemotherapy Efficacy with Histopathologic Molecular Subtypes in Breast Cancer Patients. SHILAP Revista de lepidopterología. 25(4). 274–280.

Harputluoğlu, Hakan, Mehmet Alı Nahıt Şendur, Kaplan Ma, et al.. (2024). Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes. Cancers. 16(22). 3880–3880. 3 indexed citations

Elboğa, Umut, Ertan Şahin, Tülay Kuş, et al.. (2022). Comparison of 68Ga-FAPI PET/CT and 18FDG PET/CT Modalities in Gastrointestinal System Malignancies with Peritoneal Involvement. Molecular Imaging and Biology. 24(5). 789–797. 30 indexed citations

Teker, Fatih & Umut Elboğa. (2022). Is SUVmax a useful marker for progression-free survival in patients with metastatic GEP-NET receiving ¹⁷⁷Lu-DOTATATE therapy?. PubMed. 24(2). 122–131. 6 indexed citations

Elboğa, Umut, Ertan Şahin, Tülay Kuş, et al.. (2021). Superiority of 68Ga-FAPI PET/CT scan in detecting additional lesions compared to 18FDG PET/CT scan in breast cancer. Annals of Nuclear Medicine. 35(12). 1321–1331. 72 indexed citations

Sever, Özlem Nuray, et al.. (2020). Vismodegib for Patients with Advanced Basal Cell Carcinoma: One Center’s Experience. 6(1). 5–9. 1 indexed citations

Tanrıverdi, Özgür, Serkan Menekşe, Fatih Teker, et al.. (2017). The mean platelet volume may predict the development of isolated bone metastases in patients with breast cancer: a retrospective study of the Young Researchers Committee of the Turkish Oncology Group (TOG).. PubMed. 21(4). 840–850. 20 indexed citations

Teker, Fatih, et al.. (2017). Characteristics of the Patients Undergoing Colonoscopy in a Single Center within an 8-year Period. Journal of Gastrointestinal & Digestive System. 7(3). 1 indexed citations

Erdem, Di̇lek, et al.. (2016). The effect of anticancer therapy on anti-hepatitis B antibody titres in patients with haematological malignancies and solid tumours. Journal of International Medical Research. 44(3). 627–638. 6 indexed citations

10.

Teker, Fatih, et al.. (2015). A Case of Deep Vein Thrombosis in the Postpartum Period. Journal of Academic Research in Medicine. 5(1). 28–30. 2 indexed citations

11.

Teker, Fatih, et al.. (2015). PRIMARY TESTICULAR LYMPHOMA: A SINGLE CENTRE EXPERIENCE. Experimental Oncology. 37(3). 223–226. 3 indexed citations

12.

Yalçın, Bülent, Ahmet Demirkazık, İsmail Savaş, et al.. (2015). Quality of life assesment in patients with non-small cell lung cancer patients who have or have not received second line chemotherapy. Acta Oncologica Turcica. 48(2). 53–62. 1 indexed citations

13.

Kemal, Yasemi̇n, et al.. (2015). HIGH BODY-MASS INDEX IS NOT ASSOCIATED WITH WORSE CLINICOPATHOLOGICAL CHARACTERISTICS IN PREDOMINANTLY OBESE BREAST CANCER PATIENTS. Experimental Oncology. 37(4). 281–284. 2 indexed citations

14.

Teker, Fatih, Güzin Demirağ, Di̇lek Erdem, Yasemi̇n Kemal, & İdris Yücel. (2015). Quality of life in colorectal cancer patients during chemotherapy in the era of monoclonal antibody therapies.. PubMed. 20(2). 443–51. 11 indexed citations

15.

Kemal, Yasemi̇n, et al.. (2014). Elevated Serum Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios Could be Useful in Lung Cancer Diagnosis. Asian Pacific Journal of Cancer Prevention. 15(6). 2651–2654. 100 indexed citations

16.

Teker, Fatih, et al.. (2014). Efficacy and Safety of Docetaxel or Epirubicin, Combined with Cisplatin and Fluorouracil, (DCF and ECF) Regimens as First Line Chemotherapy for Advanced Gastric Cancer: a Retrospective Analysis from Turkey. Asian Pacific Journal of Cancer Prevention. 15(16). 6727–6732. 8 indexed citations

17.

Kemal, Yasemi̇n, et al.. (2014). Single dose regorafenib-induced hypertensive crisis.. PubMed. 36(2). 134–5. 3 indexed citations

18.

Kemal, Yasemi̇n, et al.. (2014). The value of red blood cell distribution width in endometrial cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 53(5). 823–7. 40 indexed citations

19.

Erdem, Di̇lek, et al.. (2012). Brain Metastases in Gastrointestinal Cancers. Annals of Oncology. 23. ix221–ix222. 1 indexed citations

20.

Erdem, Di̇lek, et al.. (2012). Baseline lymphopenia as a prognostic marker for colorectal carcinoma.. Journal of Clinical Oncology. 30(15_suppl). e14107–e14107. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact